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Model miceAbstract Multiple sclerosis (MS) is an autoimmune disease characterized by demyelination, axo-
nal damage and progressive neurologic dysfunction in central nervous system (CNS). Many evi-
dences show that B cells play an important role in the pathogenesis of MS. Follicular helper T
cells (Tfh) secrete IL-21 to prompt the proliferation and differentiation of B cells in germinal center
(GC) through clonal proliferation, somatic hypermutation, antibody class switching, antibody
affinity maturation process. AG490 is a synthetic inhibitor to JAK-STAT signal pathway, which
has been studied in inflammatory, tumor and autoimmune diseases. In the present study, the exper-
imental mice were divided into 3 groups, vehicle group and AG490 group were given MOG35-55 to
induce EAE model, from the third day after immunization, the mice were given vehicle or AG490
by intraperitoneal injection every other day. All mice were assessed clinical scores after immuniza-
tion. On twentieth day, all mice were sacrificed, HE staining and solochrome cyanine staining were
performed to evaluate inflammatory cells infiltration and demyelination, spleen sections were
stained with PNA-FITC to analyze the difference in germinal center. Compared with vehicle group,
the incidence of AG490 group was deceased, onset time was delayed, the severity was significantly
reduced. The inflammatory cells and demyelination in AG490 group were lower than those in vehi-
cle group. Immunofluorescence showed the fluorescence intensity of AG490 group was significantly
lower than in the vehicle group, but higher than that of control group.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Multiple sclerosis (MS) is an autoimmune disease character-
ized by demyelination, axonal damage and progressive neuro-
logic dysfunction in central nervous system (CNS) (Nylander
and Hafler, 2012). Although there is no exact pathogenesis
of MS, the abnormal CD4+ helper T cells (helper T lympho-
cytes, Th) is always considered as the main reason, meanwhile
many evidences show that B cells play an important role in the
pathogenesis of MS.
More than 95% of patients with MS have been found
Oligoclonal bands (oligoclonal, bands, OCB) in their cere-
brospinal fluid examination (Freedman et al., 2005). A large
number of plasma cells have been found in acute and subacute
plaque of MS around blood vessels. Demyelination is the main
feature of brain lesions which has appeared as IgG deposition
and complement regulatory in the diagnosis of patients (Breij
et al., 2008). The studies also found that there are some relativ-
ities between antibody of virus antigen of serum and MS, such
as the titers of 1-antibody of EB virus (Epstein-Barr virus,
EBV) nuclear antigen were significantly higher than those in
normal control group (Farrell et al., 2009). The study of
pathology shows a substantial proportion of patients with sec-
ondary progressive multiple sclerosis (SPMS) in arachnoid
membrane which has ectopic lymphoid follicles, it has the
same structure as center germinal (GC) of B cell (Serafini
et al., 2004; Magliozzi et al., 2007; Howell et al., 2011). Fur-
thermore, the relapsing remitting multiple sclerosis (RRMS)
patient’s condition was significantly improved after B lympho-
cytes which can express the CD20 antigen was cleared selec-
tively by Rituxan (Hauser et al., 2008). It has achieved
similar affection in the experiment which used the second gen-
eration of Anti CD20 molecules (Barun and Bar-Or, 2012). In
recent years, the researchers have found that except the func-
tion of humoral immunity and producing antibodies, the B
cells also have negative immune regulation as the subgroup
named regulatory B cell (Breg).
It has been found that Follicular helper T cells (Tfh) are the
real T cells which participated in producing antibodies by B
cells recently (King et al., 2008). IL-21 is the main effect factor
of Tfh cells (Sarra et al., 2011). There are many cells that have
IL-21R, for example, B cells, Tfh, Thl7 and NK cells, and the
highest expression level are found in B cells (Spolski and
Leonard, 2008). IL-21 is elevated in several autoimmune dis-
eases, and the combination of IL-21 and IL-21R to activate
JAK/STAT signaling pathway is considered to be the main
cause of these disease. Tfh7 cells secrete IL-21 to prompt the
proliferation and differentiation of B cells in germinal center
(GC) through clonal proliferation, somatic hypermutation,
antibody class switching, antibody affinity maturation process,
and GC-B cells ultimately differentiate into long-lived memory
B cells and plasma cells which play a very important role in
humoral immune response (Schaerli et al., 2000).
AG490 is a kind of artificial inhibitor of JAK/STAT signal
pathway. It has the same structure as beta-parahydroxy-phe
nylpropionic acid, so it can combine with receptor tyrosine
kinase competitively and then block tyrosine or serine phos-
phorylation in the special sites of JAK, finally blocking the
activation of kinase and production of cytokine in the down-
stream. Previously, the study showed that AG490 can block
the phosphorylation of JAK2 (Meydan et al., 1996), whilethe new research suggested it can also block JAK3 in T cells
effectively (Cernkovich et al., 2008). At present, the research
of AG490 is mainly focused on tumor and inflammation,
meanwhile the results show that AG490 has good application
prospects in some autoimmune diseases. In the present study,
the immune characteristics of AG490 were evaluated in EAE
model mice, the effect of AG490 to EAE was observed by clin-
ical nerve function assessment and PNA-FITC immunofluo-
rescent staining for spleen.2. Materials and methods
2.1. Chemicals and reagents
MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK,
with the purity >95%) was synthesized by Xi’an Lianmei
(China). PTX was purchased by Alexis (Germany). Mycobac-
terium tuberculosis H37RA was provided by Difco (USA).
CFA was purchased from SigmaAldrich (USA). Sterile PBS
was purchased from Difco (USA). Fixing agent was purchased
from LiankeBio (China). The 1640 complete medium and FBS
were purchased from Gibco (USA). AG490 and DMSO were
purchased from SigmaAldrich (USA).
2.2. Development of EAE animal model
2.2.1. Animal feeding and grouping
There are thirty-six unpregnancy female mice of clean grade
C57BL/6 weighted 16–18 g from six to eight weeks old, pro-
vided by experimental animal center of Zhongshan University.
Animals were kept under controlled conditions with the tem-
perature maintained at 24 ± 2 C. The mice were acclimatized
to the housing environment for 1 week prior to the study. The
rats were fasted but provided access to water overnight before
testing began.
The number of 36 mice was adaptively fed for a week,
divided with ‘‘g” as a unit of weight stratification then the
experimental mice were divided into 3 groups (n= 12), normal
control group (control group), vehicle control group (vehicle
Group) and AG490 treatment group (AG490 group), vehicle
group and AG490 group were given MOG 35–55 to induce
EAE model, from the third day after immunization, the mice
were given vehicle or AG490 by intraperitoneal injection every
other day. The mice of control and vehicle groups were given
intraperitoneal injection with an equal volume of 5% DMSO
of sterile PBS.2.2.2. Induction of EAE model
(1) Preparation of antigen adjuvant emulsion: MOG was
diluted with aseptic PBS to 2 mg/ml, named A. The
tuberculin H37RA was dissolved in Freund’s adjuvant
completely which named B with concentration of
10 mg/ml. The equal volumes of a liquid and the B solu-
tion were then emulsified by an electric emulsifying
device for more than 30 min until the emulsion was
formed, while the water can be kept in a small ball shape
for a long time. Antigen adjuvant emulsion must be used
within 12 h.
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sterile endotoxin free PBS solution, kept at 4 C.
(3) EAE induction: Animals were injected with 0.1 ml of
antigen emulsion on both sides of the groin subcuta-
neous besides the abdomen. Then all the EAE model
mice were intraperitoneally injected with PTX solution
of 0.1 ml on the 0 day and at 48 h after processing,
respectively. On the seven days, each mouse was injected
with 0.1 ml antigen emulsion on both sides of the axil-
lary subcutaneous to enhance the immune effect. Mice
in control group were subcutaneously and intraperi-
toneally injected with the same dose of PBS.
2.2.3. Neurological function assessmenting
Blinding method was used to observe the animals after immu-
nizing. Then the mice were weighed and got neurological func-
tion score with Knno methods (Kono et al., 1998).
Following the standard below:
Level 0: no disease; Level 1: mouse tail tension reduction or
paralysis; Level 2: mouse tail paralysis, weakness of hind
limbs; Level 3: paralysis of the hind limbs in mice; Level 4:
mouse limb paralysis, man-made stand up cannot be reset;
Level 5: mouse can be morbidity and then moribund.
2.3. Drawing materials
The materials also were taken at the peak period in each
group. There are six mice that have been anesthetized by
0.1 ml of 10% chloral hydrate, then the heart was quickly
exposed for cutting the right atrial appendage. 50 ml of pre-
cooling PBS was used to wash the whole body via the left ven-
tricle till the liver and lungs becoming completely white.
Another 100 ml of 4% poly formaldehyde was given for slow
infusion, drawing was performed while the mouse to harden
the bodyv. Spinal intact and the spleen are removed and placed
in 4% poly formaldehyde at room temperature which are fixed
48 for hours, after 48 h, lumbar segments of the spinal cord
and spleen were carefully isolated and then were taken to
embed in paraffin.
There are also six mice anesthetized then put in 75% etha-
nol for 5 min, on the right side of the ice to take the spleen and
half of the spleen was cut which is put in 10% FBS containing
cold spleen at the 1640 culture medium to isolate spleen cells.
The other half of the spleen was put in freezing tubes within
liquid nitrogen and then transferred into refrigerator with
80 C for storage.
2.4. General pathology
2.4.1. HE staining
The lumbar spinal cord was embedded in paraffin which was cut
continuously by freezing microtome with the thickness was
about 4–5 lm. Put the slide into xylene - xylene - 100% alcohol
- ethanol (100%–95% alcohol - 90% alcohol - 80% alcohol -
70% alcohol in turn every process for 10 min. Then follow the
steps which are manual dewaxing-distilled water cleaning-
hematoxylin staining and where it should be continued for
10 min to stain the nuclear. Thirdly using water to clean and
dividing in 0.5% hydrochloric acid alcohol to wash out the non-
specific blue.Meanwhile soaking for 30 min to blue again, stain-ing cytoplasm by 0.5% eosin counterstain for 20–30 s, washing
nonspecific red by 80% alcohol. Finally, sliding slide into 70%
alcohol - 80% alcohol - 90% alcohol - 95% alcohol - ethanol
(100%–100% alcohol-xylene– xylene in turn and every step last
5 min to dewater, observing after mounting neutral resin.
Following the standard to observe infiltration of inflamma-
tory cell (O’Neill et al., 2006):
0 point: no cell infiltration; 1 point: the infiltration of
inflammatory cells appeared in the spinal membrane; 2 points:
inflammatory cell aggregation and infiltration in 1–2 blood
vessels; 3 points: inflammatory cell aggregation in 3–4 blood
vessels and/or a large range of 1 parenchymal involvement cell
infiltration; 4 points: a large number of cell infiltration involv-
ing albar over 20% of the region.
2.4.2. Myelin staining
Lumbar spinal cord of mice in every group was embedded and
made into series sections which were about 4–5 lm thick then
dried at 37 C deg and stained with solochrome cyanine so that
the condition can be observed.
Following were the steps: soaking the paraffin in water;
staining with solochrome cyanine for 20–30 min; watering till
them be blue; put the slices into ferric alum for 5–10 min; soak-
ing the slices in ferricyanic acid borax; dehydration and
washing.
Following the standard of Kuerten to score myelinoclasis
(Kuerten et al., 2007):
1 point: a little of subpial demyelination; 2 points: obvious
demyelination around the subpial or vascular; 3 points: the
integration of the myelin sheath around the vascular or sub-
pial; 4 points: a large number of demyelination around
perivascular or subpialcumulationa half of spinal cord, and
with CNS of inflammatory cell infiltration; 5 points: extensive
perivascular and subpial demyelination, the transverse section
of the spinal cord involvement, and with CNS parenchymal
infiltration of inflammatory cells.
2.5. Immunofluorescence
(1) Preparation of paraffin sections of mouse spleen tissue; (2)
The paraffin section was put in the oven of 60 C for 60 min, to
conventionally dewax; (3) The paraffin sections was put in
0.1% Triton-100 solution (dissolved in PBS) in room temper-
ature static for 5 min; (4) PNA-FITC (100 lg/ml) was dropped
on the paraffin section to incubate for 30 min avoiding light
37 C , washed with PBS for 3 min  3; (5) Adding DAPI solu-
tion, light 37 C and incubated for 10 min PBS wash
3 min  3; (6) Glycerol under fluorescence microscope.
2.6. Statistical analysis
Statistical analysis was carried out by SPSS16.0, all data were
expressed in this standard which is mean ± SD. A one-way
ANOVA was used for pairwise comparisons while the results
meeting normality and homoscedasticity, the least significant
difference method (LSD) was also used and was considered
statistically significant while P< 0.05. Kruskal-Wallis was
used for nonparametric test while not meeting the normality
or homoscedasticity, Mann-Whitney U-test was used for pair-
wise comparisons and was considered statistically significant
while is P< 0.05.
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3.1. General situation, incidence and clinical score of mice
There was no abnormal nervous system performance in nor-
mal control group (control group) in the process of experi-
ment. The general situation of nosopoietic murine
appearance changed significantly, such as the appearance of
hair was not smooth, eat less, weight loss, reaction to the out-
side stimulation unresponsive, showed the tail down to the
floor, gait unsteady, limb weakness, then developed to limb
paralysis, involving bilateral hindlimb, serious mice appear
quadriplegia. Immunohistochemistry results showed, com-
pared with vehicle group (22.58 ± 9.21 vs 7.5 ± 3.40), the
expressions were decreased in AG490 group, have statistical
significance (P= 0.01) (Table 1 and Fig. 1). Solvent control
group (Vehicle Group) mice on the 12th day of onset, the med-
ian time to onset of 12.83 + 1.47 days. The mice in AG490
treatment group on the 14th day of onset, the median timeTable 1 The clinical features and pathological score of vehicle grou
Processing Onset Cumulative score
Vehicle 12.83 ± 1.47 22.58 ± 9.21
AG490 16.16 ± 1.21** 7.5 ± 3.40**
* Compared with the vehicle group, P< 0.05.
** Compared with the vehicle group, P< 0.01.
Figure 1 AG490 delayed the onset time of EAE mice and significa
group and AG490 treatment group, the cumulative clinical score, the av
the mice before and after A: immunization. *: compared with the vehiclto onset of 16.16 + 1.21 days, obviously express later than
vehicle group which has statistical significance (Table 1 and
Fig. 1). Thus, compared with the vehicle group, AG490 treat-
ment group can effectively reduce the incidence of EAE mice,
delay time of onset, and can significantly reduce the severity of
the disease.
3.2. Pathological changes of myeloid tissue in mice
HE staining showed that the vehicle group in the myeloid tis-
sue of mice have infiltration of a large number of inflammatory
cell, inflammatory cells mainly gathered around the spinal pia
mater and vascular, forming the structure like ‘‘cuff” (Fig. 2).
Inflammatory cells were significantly reduced which was dealt
with AG490 and was significantly lower compared with vehicle
group (2.67 ± 0.47 vs 1.50 ± 0.50) with statistical significance
(P= 0.011) (Table 1 and Fig 3). Solochrome cyanine staining
showed that vehicle group mouse had myelinoclasis in substan-
tia alba medullae spinalis and a large number of inflammatoryp and AG490 group.
Inflammation Demyelination Incidence
2.67 ± 0.47 3.50 ± 0.5 91.70%
1.50 ± 0.50* 1.67 ± 0.75** 62.20%*
ntly improved its neurological function. Clinical score, B: vehicle
erage onset time of C: vehicle and AG490 treatment group were all
e group, P< 0.05, **: compared with the vehicle group, P< 0.01.
Figure 2 AG490 significantly reduced the pathological changes in EAE mice, inflammatory cell infiltration and changes in the lumbar
spinal cord were significantly reduced. A, B, for HE staining, C, D for the sand LuoLuo cyanine dye; a, B and C AG490 group mice, B, D
vehicle mice; a, B, C, D for corresponding local amplification. Six mice in each group.
Figure 3 AG490 significantly reduced the inflammatory score
and the score of the EAE mice, *: compared with the P group,
vehicle <0.05, **: compared with the P group, vehicle <0.01. Six
mice in each group.
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reduced which was dealt with AG490 and was significantly
lower compared with vehicle group (3.50 ± 0.50 vs 1.67
± 0.75) also with statistical significance (P= 0.006) (Table 1
and Fig. 3).
3.3. The formation of GC in the spleen of each group was
analyzed by immunofluorescence microscopy PNA-FITC
staining
B cell can be shown by PNA (+) when it was in the early
stages. The weakest PNA (+) green fluorescent in the control
group suggesting the less non-immuned mice, meanwhile the
strongest green fluorescent in the vehicle group suggesting
the large number of GC cells in EAE model mice. In AG490
treatment group, the green fluorescence of PNA (+) compared
with the vehicle group decreased significantly but still higher
than the control group (Fig. 4).
Figure 4 The spleen sections of each group PNA-FITC staining immunofluorescence microscopy results (400, Bar = 100 m), AG490
significantly reduced the formation of GC in EAE mice. PNA and fluorescein FITC connection, PNA positive cells showed green
fluorescence, DAPI staining showed blue. Six mice in each group.
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4.1. Development of EAE model
EAE are MS disease models that are induced by myelin anti-
gen and peptide in experimental animals. It is considered as
the ideal experimental tool of MS which has the similar aspects
in clinical manifestations and pathology with MS. There are
three myelin antigens which is consisted of myelin protein pro-
tein (PLP), myelin basic protein (MBP) and myelin glycopro-
tein (MOG) and induce EAE. MOG as transmembrane
protein can be expressed out of myelin membrane and oligo-
dendroglia which is only the total myelin protein 0.05–0.1%
several times, but it has high immunogenicity and it as the
key part can cause cerebritis (Mendel et al., 1995). The back-
ground of C57BL/6 mice has been clarified and incidence of
a disease is really high which has a wide application in EAE.
Meanwhile the mice have been immunized by MOG35-55
which have the similar nosogenesis with MS.
4.2. AG490 in medical treatment
At present, AG490 has shown good application prospects in
the study of tumor, inflammation and some autoimmune dis-
eases. In vitro study showed that AG490 not only can inhibit
the proliferation and induced apoptosis of tumor cells, but also
can block the JAK2/STAT3 signal of colorectal cancer cells. Inmacrophages, AG490 inhibited the production of IFN-c and
nitric oxide by nitric oxide synthase, and reduced the release
of TNF-a. In animal models, the number of CD4+CD25
+Foxp3+ cells has been in type I diabetic mouse model by
increasing the dependent dose model of AG490 which affects
the development of the disease. Induced shock response by
yeast polysaccharide, AG490 decreased the severity of the
inflammatory response and prevented severe renal dysfunc-
tion. In model that collagen induces arthritis, AG490 induced
the formation of Treg and inhibited the differentiation of
Th17 by inhibiting the JAK2/STAT3 signaling pathway, which
significantly reduced the severity of the disease. AG490 is still
rarely seen in the study of EAE. The present study shows
that AG490 can inhibit the invasion of T cells and delay or
inhibit the occurrence of antigen specificity (Constantin
et al., 1998).
With the IC50 of 10 M, the range of maximum effective con-
centration is 50–100 M equaling to 20–40 mg/kg of AG490
(Seeger et al., 2007). In this study, each mouse was given
500 g, which is equal to 25 mg/kg. Our results showed that
the experimental mice had the good tolerance dose. AG490
had significant neuroprotection which significantly delayed
the onset time, significantly reduced the disease and treated
the pathogenesis of EAE mice. Lumbar segments of the spinal
cord were stained by HE and sand LuoLuo cyanine also con-
firmed that infiltration and demyelination degree of AG490
group mice inflammatory cells decreased significantly. The
phosphorylation of STAT3 was obviously inhibited, and the
262 Z. Zhao et al.number of B, Tfh cells, plasma cells and so on were decreased
significantly.
4.3. Effect of AG490 on Tfh
Chemokine receptor CXCR5 sustained high expression trend
by Tfh, which are migrated and located in folliculi lymphaticus
by chemokine CXCL13. These cells express ICOS, PD1,
CD40L and other molecules on the surface and secret IL-21
cytokines and interact with B cells, B cells of auxiliary GC
are proliferation and differentiation, experiencing clonal pro-
liferation and somatic high mutation, antibody class switching,
antibody affinity maturation and process, then ultimately dif-
ferentiate into long-lived memory B cells and plasma cells, in
the humoral immune response plays an important role (Ge
et al., 2015). TFH becoming a bridge between humoral immu-
nity and cellular immunity that is produced by auxiliary B cells
in real meaning. Th1, Th2 and Th17 cells in GC formation and
provide assistance to B cells are not necessarily required. The
differentiation of Th2, Th17 and Th1 were dependent on T-
bet, GATA-3, ROR, Foxp3, Treg and T, respectively, and
the transcription factors were not highly expressed in Tfh cells.
Research shows B cell lymphoma factor 6 (B cell lymphoma 6
bcl-6) is TFH transcription factor, bcl-6 defect of T cells could
not differentiate into TFH cells, almost cannot produce the
GC reaction, confirmed that bcl-6 exist (Peng et al., 2014).
Although there are other CD4+ T cell subsets that may
also turn into TFH cells in some special or high GC reaction
environment, as isolated CD4+ T cell subsets that have been
recognized gradually (Xiao et al., 2013). Recently, studies have
shown that transcription factor B lymphocytes induce mature
protein (lymphocyte-induced maturation protein-1 B, Blimp-1)
to inhibit the role of Bcl-6, thus inhibiting the differentiation of
Tfh.
In MS patients, several studies have reported that the ratio
of Tfh in peripheral blood is higher than that in healthy con-
trols. Our study showed that the ratio of Tfh was significantly
higher in the vehicle group than in the control group, whereas
the Tfh ratio was significantly decreased in the AG490 treated
mice compared with the vehicle group. Results of western blot
also showed that the number of different groups of TFH tran-
scription factor bcl-6 expression trend and its corresponding
TFH ratio trend is similar to that of AG490 inhibits TFH dif-
ferentiation was further confirmed, reducing the TFH, which
can achieve the purpose of restraining the inflammation and
improving the symptoms.References
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